IL19 and psoriasis: Thus, a serum IL-19 assay might be considered not only for replacing or augmenting visual assessment tools used to categorize psoriasis severity, but also for documenting the timing of the therapeutic responses, assessing the degree of efficacy, and serving as a harbinger of relapse when treatments need to be discontinued.